Autologous platelet transfusion in alloimmunized patients with acute leukemia. 1995

I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
Department of Hematology and Oncology, University of Ulm, Germany.

Seventy-eight transfusions of autologous platelets were given to eight alloimmunized patients receiving curative chemotherapy for acute leukemia. Platelets were collected at regeneration of hematopoiesis after a chemotherapy cycle, cryopreserved with 5% dimethylsulfoxide in liquid nitrogen, and retransfused during bone marrow aplasia following the next treatment cycle. The in vitro platelet recovery after freezing, thawing, and washing was 85 +/- 4%. The in vivo corrected count increment 1 h after autologous platelet transfusions was 11 +/- 5 x 10(9)/l. With the exception of moderate urticaria and slight nausea each after one transfusion, no immediate or chronic side effects occurred. The bleeding time was shortened and hemorrhage during bone marrow aplasia was prevented in all alloimmunized patients by autologous platelet transfusions.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D001804 Blood Transfusion, Autologous Reinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed) Autotransfusion,Autologous Blood Transfusion,Autologous Blood Transfusions,Blood Transfusions, Autologous,Transfusion, Autologous Blood,Transfusions, Autologous Blood,Autotransfusions

Related Publications

I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
July 1978, The New England journal of medicine,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
November 2010, Transfusion,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
January 1978, Progress in clinical and biological research,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
March 1977, Transplantation proceedings,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
January 1985, Transfusion,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
March 1987, British journal of haematology,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
August 2000, Bone marrow transplantation,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
January 1987, Transfusion,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
February 1981, The American journal of medical technology,
I Funke, and M Wiesneth, and K Koerner, and M Cardoso, and E Seifried, and B Kubanek, and H Heimpel
October 1984, Blood,
Copied contents to your clipboard!